Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19

Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis Drug Effective Against COVID-19

A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.” Targeting 340 participants, this study was completed in late August. This included a total of 304 participated, 203 participants in the ivermectin group and 101 in the control group. The goal of this investigation was to determine whether ivermectin could serve as a prophylactic and included a 14 day follow-up period involving a diagnosis for symptoms of COVID-19. The findings reveal that ivermectin demonstrates statistically significant benefits for use as a prophylaxis to prevent symptomatic COVID-19 infection in individuals that have been exposed to close family members diagnosed with COVID-19. This study confirms the author’s hypothesis that ivermectin in fact possesses an antiviral effect and demonstrates efficacy in preventing the development of symptomatic infection for those individuals that have come in close contact to family members diagnosed with COVID-19. Importantly, these findings haven’t been peer reviewed nor published in ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee